DK175460B1 - Fremgangsmåde til fremstilling af et pattedyrpolypeptid - Google Patents

Fremgangsmåde til fremstilling af et pattedyrpolypeptid Download PDF

Info

Publication number: DK175460B1
Authority: DK; Denmark
Prior art keywords: dna; sequence; fragment; aspergillus; polypeptide
Prior art date: 1985-08-29

Application number

DK414486A

Other languages

Danish (da)

English (en)

Other versions

DK414486D0 (da

DK414486A (da

Inventor

Kirk J Hayenga

Randy M Berka

Daniel Cullen

Gregory L Gray

Virgil B Lawlis

Original Assignee

Genencor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-08-29

Filing date

1986-08-29

Publication date

2004-11-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27118452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK175460(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1986-08-29 Application filed by Genencor Inc filed Critical Genencor Inc

1986-08-29 Publication of DK414486D0 publication Critical patent/DK414486D0/da

1987-03-01 Publication of DK414486A publication Critical patent/DK414486A/da

2004-11-01 Application granted granted Critical

2004-11-01 Publication of DK175460B1 publication Critical patent/DK175460B1/da

Links

102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 102
108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 102
229920001184 polypeptide Polymers 0.000 title claims abstract description 101
238000000034 method Methods 0.000 title claims abstract description 55
230000008569 process Effects 0.000 title abstract description 5
239000013598 vector Substances 0.000 claims abstract description 68
241000233866 Fungi Species 0.000 claims abstract description 47
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 41
108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 32
230000008488 polyadenylation Effects 0.000 claims abstract description 10
230000003248 secreting effect Effects 0.000 claims abstract description 7
230000001131 transforming effect Effects 0.000 claims abstract description 3
108020004414 DNA Proteins 0.000 claims description 79
241000351920 Aspergillus nidulans Species 0.000 claims description 54
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 53
108090000746 Chymosin Proteins 0.000 claims description 48
102100022624 Glucoamylase Human genes 0.000 claims description 44
108091005804 Peptidases Proteins 0.000 claims description 44
239000004365 Protease Substances 0.000 claims description 41
230000009466 transformation Effects 0.000 claims description 33
230000028327 secretion Effects 0.000 claims description 25
241000235403 Rhizomucor miehei Species 0.000 claims description 23
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 22
241001513093 Aspergillus awamori Species 0.000 claims description 21
102000004190 Enzymes Human genes 0.000 claims description 17
108090000790 Enzymes Proteins 0.000 claims description 17
108090000623 proteins and genes Proteins 0.000 claims description 16
241000228212 Aspergillus Species 0.000 claims description 15
101150008194 argB gene Proteins 0.000 claims description 14
230000002538 fungal effect Effects 0.000 claims description 12
101000757144 Aspergillus niger Glucoamylase Proteins 0.000 claims description 8
101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 claims description 8
241000223199 Humicola grisea Species 0.000 claims description 8
241000235395 Mucor Species 0.000 claims description 8
101150039489 lysZ gene Proteins 0.000 claims description 8
241000223259 Trichoderma Species 0.000 claims description 5
241000221960 Neurospora Species 0.000 claims description 4
101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 claims description 4
101150016309 trpC gene Proteins 0.000 claims description 4
108010048241 acetamidase Proteins 0.000 claims description 3
241001246273 Endothia Species 0.000 claims description 2
241000221945 Podospora Species 0.000 claims description 2
230000002708 enhancing effect Effects 0.000 claims description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 3
108091061763 Triple-stranded DNA Proteins 0.000 claims 1
235000015278 beef Nutrition 0.000 claims 1
230000000644 propagated effect Effects 0.000 claims 1
230000005030 transcription termination Effects 0.000 claims 1
239000012634 fragment Substances 0.000 description 124
239000013612 plasmid Substances 0.000 description 76
230000014509 gene expression Effects 0.000 description 54
229940080701 chymosin Drugs 0.000 description 43
GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 41
102000035195 Peptidases Human genes 0.000 description 38
230000000694 effects Effects 0.000 description 31
239000002609 medium Substances 0.000 description 30
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 20
238000006243 chemical reaction Methods 0.000 description 20
108091034117 Oligonucleotide Proteins 0.000 description 19
108020004705 Codon Proteins 0.000 description 18
238000010276 construction Methods 0.000 description 18
229940088598 enzyme Drugs 0.000 description 18
238000009396 hybridization Methods 0.000 description 18
239000000523 sample Substances 0.000 description 18
229920001817 Agar Polymers 0.000 description 17
241000228245 Aspergillus niger Species 0.000 description 17
239000008272 agar Substances 0.000 description 17
108010064037 prorennin Proteins 0.000 description 17
241000588724 Escherichia coli Species 0.000 description 15
150000001413 amino acids Chemical group 0.000 description 14
239000000499 gel Substances 0.000 description 13
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
240000004808 Saccharomyces cerevisiae Species 0.000 description 12
241000499912 Trichoderma reesei Species 0.000 description 12
230000001580 bacterial effect Effects 0.000 description 12
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 11
108091008146 restriction endonucleases Proteins 0.000 description 11
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 10
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 10
230000029087 digestion Effects 0.000 description 10
239000000203 mixture Substances 0.000 description 10
229950000964 pepstatin Drugs 0.000 description 10
108010091212 pepstatin Proteins 0.000 description 10
FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 10
239000000725 suspension Substances 0.000 description 10
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 10
229940045145 uridine Drugs 0.000 description 10
108091005508 Acid proteases Proteins 0.000 description 9
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
241000221961 Neurospora crassa Species 0.000 description 9
235000001014 amino acid Nutrition 0.000 description 9
230000004927 fusion Effects 0.000 description 9
239000002773 nucleotide Substances 0.000 description 9
125000003729 nucleotide group Chemical group 0.000 description 9
101000914103 Bos taurus Chymosin Proteins 0.000 description 8
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
108091026890 Coding region Proteins 0.000 description 8
238000004458 analytical method Methods 0.000 description 8
102100022422 cGMP-dependent protein kinase 1 Human genes 0.000 description 8
229910052799 carbon Inorganic materials 0.000 description 8
210000004027 cell Anatomy 0.000 description 8
238000003776 cleavage reaction Methods 0.000 description 8
235000018102 proteins Nutrition 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
230000007017 scission Effects 0.000 description 8
108020005029 5' Flanking Region Proteins 0.000 description 7
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
230000000295 complement effect Effects 0.000 description 7
239000013604 expression vector Substances 0.000 description 7
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
238000002741 site-directed mutagenesis Methods 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
108020005065 3' Flanking Region Proteins 0.000 description 6
102000002260 Alkaline Phosphatase Human genes 0.000 description 6
108020004774 Alkaline Phosphatase Proteins 0.000 description 6
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
239000000020 Nitrocellulose Substances 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
108091081024 Start codon Proteins 0.000 description 6
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
230000002378 acidificating effect Effects 0.000 description 6
229960000723 ampicillin Drugs 0.000 description 6
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 6
238000001962 electrophoresis Methods 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
239000004744 fabric Substances 0.000 description 6
239000001963 growth medium Substances 0.000 description 6
230000010354 integration Effects 0.000 description 6
238000002703 mutagenesis Methods 0.000 description 6
231100000350 mutagenesis Toxicity 0.000 description 6
229920001220 nitrocellulos Polymers 0.000 description 6
210000001938 protoplast Anatomy 0.000 description 6
239000000243 solution Substances 0.000 description 6
239000000758 substrate Substances 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
239000004098 Tetracycline Substances 0.000 description 5
230000004071 biological effect Effects 0.000 description 5
239000000872 buffer Substances 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
239000008103 glucose Substances 0.000 description 5
238000011534 incubation Methods 0.000 description 5
238000005259 measurement Methods 0.000 description 5
238000012163 sequencing technique Methods 0.000 description 5
238000012360 testing method Methods 0.000 description 5
229960002180 tetracycline Drugs 0.000 description 5
229930101283 tetracycline Natural products 0.000 description 5
235000019364 tetracycline Nutrition 0.000 description 5
150000003522 tetracyclines Chemical class 0.000 description 5
238000013519 translation Methods 0.000 description 5
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
101100314150 Caenorhabditis elegans tank-1 gene Proteins 0.000 description 4
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
108010062466 Enzyme Precursors Proteins 0.000 description 4
102000010911 Enzyme Precursors Human genes 0.000 description 4
RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 4
RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 4
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 4
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
229920002472 Starch Polymers 0.000 description 4
230000004913 activation Effects 0.000 description 4
229960004050 aminobenzoic acid Drugs 0.000 description 4
239000001110 calcium chloride Substances 0.000 description 4
229910001628 calcium chloride Inorganic materials 0.000 description 4
235000011148 calcium chloride Nutrition 0.000 description 4
229940041514 candida albicans extract Drugs 0.000 description 4
229960002173 citrulline Drugs 0.000 description 4
235000013477 citrulline Nutrition 0.000 description 4
239000013599 cloning vector Substances 0.000 description 4
230000002950 deficient Effects 0.000 description 4
239000008121 dextrose Substances 0.000 description 4
239000011521 glass Substances 0.000 description 4
230000012010 growth Effects 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
239000000543 intermediate Substances 0.000 description 4
238000002955 isolation Methods 0.000 description 4
125000005647 linker group Chemical group 0.000 description 4
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 4
239000002243 precursor Substances 0.000 description 4
101150089778 pyr-4 gene Proteins 0.000 description 4
230000008929 regeneration Effects 0.000 description 4
238000011069 regeneration method Methods 0.000 description 4
239000001632 sodium acetate Substances 0.000 description 4
235000017281 sodium acetate Nutrition 0.000 description 4
239000008107 starch Substances 0.000 description 4
235000019698 starch Nutrition 0.000 description 4
239000012138 yeast extract Substances 0.000 description 4
ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
102000012410 DNA Ligases Human genes 0.000 description 3
108010061982 DNA Ligases Proteins 0.000 description 3
108700039691 Genetic Promoter Regions Proteins 0.000 description 3
101000669432 Homo sapiens Transducin-like enhancer protein 1 Proteins 0.000 description 3
101000801209 Homo sapiens Transducin-like enhancer protein 4 Proteins 0.000 description 3
102000002265 Human Growth Hormone Human genes 0.000 description 3
108010000521 Human Growth Hormone Proteins 0.000 description 3
239000000854 Human Growth Hormone Substances 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
239000006142 Luria-Bertani Agar Substances 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
102000003978 Tissue Plasminogen Activator Human genes 0.000 description 3
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 3
102100039362 Transducin-like enhancer protein 1 Human genes 0.000 description 3
102100033763 Transducin-like enhancer protein 4 Human genes 0.000 description 3
239000008346 aqueous phase Substances 0.000 description 3
235000003704 aspartic acid Nutrition 0.000 description 3
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
238000000605 extraction Methods 0.000 description 3
238000001914 filtration Methods 0.000 description 3
238000001502 gel electrophoresis Methods 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
239000003550 marker Substances 0.000 description 3
235000013336 milk Nutrition 0.000 description 3
239000008267 milk Substances 0.000 description 3
210000004080 milk Anatomy 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
150000007523 nucleic acids Chemical class 0.000 description 3
239000012071 phase Substances 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
229920000053 polysorbate 80 Polymers 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000012545 processing Methods 0.000 description 3
101150054232 pyrG gene Proteins 0.000 description 3
238000011160 research Methods 0.000 description 3
239000004576 sand Substances 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
238000007711 solidification Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
229960000187 tissue plasminogen activator Drugs 0.000 description 3
108010038550 3-dehydroquinate dehydratase Proteins 0.000 description 2
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
244000153158 Ammi visnaga Species 0.000 description 2
235000010585 Ammi visnaga Nutrition 0.000 description 2
239000004475 Arginine Substances 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000193830 Bacillus <bacterium> Species 0.000 description 2
101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 2
108091005658 Basic proteases Proteins 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
101100407084 Caenorhabditis elegans parp-2 gene Proteins 0.000 description 2
229920000298 Cellophane Polymers 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
102000001690 Factor VIII Human genes 0.000 description 2
108010054218 Factor VIII Proteins 0.000 description 2
108700007698 Genetic Terminator Regions Proteins 0.000 description 2
102000016901 Glutamate dehydrogenase Human genes 0.000 description 2
108091006905 Human Serum Albumin Proteins 0.000 description 2
102000008100 Human Serum Albumin Human genes 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
108020005187 Oligonucleotide Probes Proteins 0.000 description 2
102100037214 Orotidine 5'-phosphate decarboxylase Human genes 0.000 description 2
108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
108090000284 Pepsin A Proteins 0.000 description 2
102000057297 Pepsin A Human genes 0.000 description 2
239000001888 Peptone Substances 0.000 description 2
108010080698 Peptones Proteins 0.000 description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
108020005091 Replication Origin Proteins 0.000 description 2
244000061456 Solanum tuberosum Species 0.000 description 2
235000002595 Solanum tuberosum Nutrition 0.000 description 2
239000007984 Tris EDTA buffer Substances 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
240000008042 Zea mays Species 0.000 description 2
235000002017 Zea mays subsp mays Nutrition 0.000 description 2
239000002253 acid Substances 0.000 description 2
238000005273 aeration Methods 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
238000003556 assay Methods 0.000 description 2
238000000211 autoradiogram Methods 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
230000001851 biosynthetic effect Effects 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
235000013351 cheese Nutrition 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 2
239000013611 chromosomal DNA Substances 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
238000010367 cloning Methods 0.000 description 2
239000012531 culture fluid Substances 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
238000004925 denaturation Methods 0.000 description 2
230000036425 denaturation Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
229960000301 factor viii Drugs 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
239000004570 mortar (masonry) Substances 0.000 description 2
230000035772 mutation Effects 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
239000002751 oligonucleotide probe Substances 0.000 description 2
239000008188 pellet Substances 0.000 description 2
229940111202 pepsin Drugs 0.000 description 2
235000019319 peptone Nutrition 0.000 description 2
101150047627 pgk gene Proteins 0.000 description 2
235000021317 phosphate Nutrition 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
239000006187 pill Substances 0.000 description 2
239000000843 powder Substances 0.000 description 2
239000000047 product Substances 0.000 description 2
239000000700 radioactive tracer Substances 0.000 description 2
238000004153 renaturation Methods 0.000 description 2
230000010076 replication Effects 0.000 description 2
230000003362 replicative effect Effects 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000013606 secretion vector Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000011734 sodium Substances 0.000 description 2
230000008023 solidification Effects 0.000 description 2
241000894007 species Species 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
229960005356 urokinase Drugs 0.000 description 2
230000009105 vegetative growth Effects 0.000 description 2
238000005406 washing Methods 0.000 description 2
238000001262 western blot Methods 0.000 description 2
PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
JEOQACOXAOEPLX-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;1,3-thiazolidine-4-carboxylic acid Chemical compound OC(=O)C1CSCN1.OC(=O)[C@@H](N)CCCN=C(N)N JEOQACOXAOEPLX-WCCKRBBISA-N 0.000 description 1
NRZZLYODXDSLEK-UHFFFAOYSA-N (6-ethoxy-6-oxohexyl) 3,5-diacetamido-2,4,6-triiodobenzoate Chemical compound CCOC(=O)CCCCCOC(=O)C1=C(I)C(NC(C)=O)=C(I)C(NC(C)=O)=C1I NRZZLYODXDSLEK-UHFFFAOYSA-N 0.000 description 1
WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 description 1
BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 4-nitrophenyl alpha-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 0.000 description 1
RNBMPPYRHNWTMA-UAKXSSHOSA-N 5-fluorouridine 5'-monophosphate Chemical compound O1[C@H](COP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1N1C(=O)NC(=O)C(F)=C1 RNBMPPYRHNWTMA-UAKXSSHOSA-N 0.000 description 1
FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
240000006439 Aspergillus oryzae Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
108090000489 Carboxy-Lyases Proteins 0.000 description 1
229920002101 Chitin Polymers 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
230000007067 DNA methylation Effects 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
108010056771 Glucosidases Proteins 0.000 description 1
102000004366 Glucosidases Human genes 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
241000223198 Humicola Species 0.000 description 1
241001138401 Kluyveromyces lactis Species 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
125000000773 L-serino group Chemical group [H]OC(=O)[C@@]([H])(N([H])*)C([H])([H])O[H] 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
241001625930 Luria Species 0.000 description 1
102100024295 Maltase-glucoamylase Human genes 0.000 description 1
229920002774 Maltodextrin Polymers 0.000 description 1
239000005913 Maltodextrin Substances 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
241000231139 Pyricularia Species 0.000 description 1
101150053899 RSH1 gene Proteins 0.000 description 1
101150095719 RSH2 gene Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
239000012722 SDS sample buffer Substances 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
241000228417 Sarocladium strictum Species 0.000 description 1
241001275117 Seres Species 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000282887 Suidae Species 0.000 description 1
101150006914 TRP1 gene Proteins 0.000 description 1
241000030538 Thecla Species 0.000 description 1
241000223261 Trichoderma viride Species 0.000 description 1
CNNVVEPJTFOGHI-ACRUOGEOSA-N Tyr-Lys-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CNNVVEPJTFOGHI-ACRUOGEOSA-N 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
102000004139 alpha-Amylases Human genes 0.000 description 1
108090000637 alpha-Amylases Proteins 0.000 description 1
108010028144 alpha-Glucosidases Proteins 0.000 description 1
229940126575 aminoglycoside Drugs 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000002518 antifoaming agent Substances 0.000 description 1
239000012223 aqueous fraction Substances 0.000 description 1
101150102858 aroD gene Proteins 0.000 description 1
101150040872 aroE gene Proteins 0.000 description 1
101150108612 aroQ gene Proteins 0.000 description 1
238000000429 assembly Methods 0.000 description 1
230000000712 assembly Effects 0.000 description 1
RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
235000010633 broth Nutrition 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
230000030833 cell death Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
230000001112 coagulating effect Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000010668 complexation reaction Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
230000007547 defect Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
238000010612 desalination reaction Methods 0.000 description 1
239000012470 diluted sample Substances 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
230000006334 disulfide bridging Effects 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
230000002070 germicidal effect Effects 0.000 description 1
239000006481 glucose medium Substances 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
238000000227 grinding Methods 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
235000019534 high fructose corn syrup Nutrition 0.000 description 1
229920006158 high molecular weight polymer Polymers 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
238000002372 labelling Methods 0.000 description 1
238000002386 leaching Methods 0.000 description 1
238000011068 loading method Methods 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
235000009973 maize Nutrition 0.000 description 1
229940035034 maltodextrin Drugs 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000000463 material Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000021121 meiosis Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000006151 minimal media Substances 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
FKCRAVPPBFWEJD-XVFCMESISA-N orotidine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1C(O)=O FKCRAVPPBFWEJD-XVFCMESISA-N 0.000 description 1
FKCRAVPPBFWEJD-UHFFFAOYSA-N orotidine Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1C(O)=O FKCRAVPPBFWEJD-UHFFFAOYSA-N 0.000 description 1
230000037361 pathway Effects 0.000 description 1
238000002205 phenol-chloroform extraction Methods 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
108010055837 phosphocarrier protein HPr Proteins 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
238000007747 plating Methods 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
239000013641 positive control Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
238000007790 scraping Methods 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000035939 shock Effects 0.000 description 1
239000013605 shuttle vector Substances 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
239000002002 slurry Substances 0.000 description 1
239000007974 sodium acetate buffer Substances 0.000 description 1
VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
229960002385 streptomycin sulfate Drugs 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
108091008023 transcriptional regulators Proteins 0.000 description 1
238000012546 transfer Methods 0.000 description 1
SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000003462 zymogenic effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
- C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Mycology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)

DK414486A 1985-08-29 1986-08-29 Fremgangsmåde til fremstilling af et pattedyrpolypeptid DK175460B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US77137485A	1985-08-29	1985-08-29
US77137485		1985-08-29
US88222486A	1986-07-07	1986-07-07
US88222486		1986-07-07

Publications (3)

Publication Number	Publication Date
DK414486D0 DK414486D0 (da)	1986-08-29
DK414486A DK414486A (da)	1987-03-01
DK175460B1 true DK175460B1 (da)	2004-11-01

Family

ID=27118452

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK414486A DK175460B1 (da)	1985-08-29	1986-08-29	Fremgangsmåde til fremstilling af et pattedyrpolypeptid

Country Status (10)

Country	Link
EP (2)	EP0625577A1 (de)
JP (1)	JPH08280388A (de)
AT (1)	ATE117020T1 (de)
AU (1)	AU607398B2 (de)
CA (1)	CA1341532C (de)
DE (1)	DE3650202T3 (de)
DK (1)	DK175460B1 (de)
HK (1)	HK1003579A1 (de)
IE (2)	IE65794B1 (de)
NZ (1)	NZ217373A (de)

Families Citing this family (127)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4885249A (en) *	1984-12-05	1989-12-05	Allelix, Inc.	Aspergillus niger transformation system
GB8508800D0 (en) *	1985-04-04	1985-05-09	Glaxo Group Ltd	Microbiological process
US5198345A (en)	1985-04-15	1993-03-30	Gist-Brocades N.V.	Vectors in use in filamentous fungi
DE3650783T2 (de) *	1985-04-15	2004-07-15	Dsm Ip Assets B.V.	Verwendung des Glucoamylasepromotors aus Apergillus
DK122686D0 (da) *	1986-03-17	1986-03-17	Novo Industri As	Fremstilling af proteiner
US5536661A (en) *	1987-03-10	1996-07-16	Novo Nordisk A/S	Process for the production of protein products in aspergillus
US5766912A (en)	1986-03-17	1998-06-16	Novo Nordisk A/S	Humicola lipase produced in aspergillus
GB8610600D0 (en) *	1986-04-30	1986-06-04	Novo Industri As	Transformation of trichoderma
US5780292A (en) *	1987-04-29	1998-07-14	Alko Group Ltd.	Production of phytate degrading enzymes in trichoderma
US5610034A (en) *	1987-04-29	1997-03-11	Alko Group Ltd.	Immunoglobulin production by trichoderma
DE3854249T2 (de) *	1987-08-28	1996-02-29	Novonordisk As	Rekombinante Humicola-Lipase und Verfahren zur Herstellung von rekombinanten Humicola-Lipasen.
EP0383779B2 (de) *	1987-09-04	2000-05-31	Novo Nordisk A/S	VERFAHREN ZUR HERSTELLUNG VON PROTEINPRODUKTEN IN $i(ASPERGILLUS) UND PROMOTOREN ZUR VERWENDUNG IN $i(ASPERGILLUS)
CA1333777C (en)	1988-07-01	1995-01-03	Randy M. Berka	Aspartic proteinase deficient filamentous fungi
DE69032616T2 (de) *	1989-06-16	1999-03-11	Genencor International, Inc., Rochester, N.Y.	Dna-sequenzen, vektoren und fusionspolypeptide zur erhöhung der sekretion gewünschter polypeptide von filamentösen fungi
FR2649120B1 (fr) *	1989-06-30	1994-01-28	Cayla	Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
AU7493491A (en) *	1990-03-13	1991-10-10	Hawaii Biotechnology Group, Inc.	(neurospora) expression system
CA2084189A1 (en) *	1990-07-16	1992-01-17	Alko Group Limited	Immunoglobulin production by trichoderma
CA2106485A1 (en) *	1991-03-22	1992-09-23	Henrik Dalboge	Process for producing heme proteins
WO1992016633A1 (en) *	1991-03-22	1992-10-01	Novo Nordisk A/S	A process for producing chymosin
DK36592D0 (da) *	1992-03-20	1992-03-20	Novo Nordisk As	Fremgangsmaade til fremstilling af proteiner
JPH09505201A (ja) *	1992-07-31	1997-05-27	パンラブスインコーポレイテッド	組換え細胞、ｄｎａ構造、ベクター及びフィチン酸塩分解酵素を任意の比率で発現する方法
DE69432543T2 (de) *	1993-07-23	2003-12-24	Dsm N.V., Te Heerlen	Selektionmarker-genfreie rekombinante Stämme: Verfahren zur ihrer Herstellung und die Verwendung dieser Stämme
US6300114B1 (en) *	1994-07-29	2001-10-09	Rohm Enzyme Finland Oy	Sequences of xylanase and xylanase expression vectors
US5935836A (en) *	1994-07-29	1999-08-10	Rohm Enzyme Finland Oy	Actinomadura xylanase sequences and methods of use
US7816129B2 (en)	1994-07-29	2010-10-19	Ab Enzymes Gmbh	Production and secretion of proteins of bacterial origin in filamentous fungi
US5700686A (en) *	1995-06-06	1997-12-23	Iogen Corporation	Protease-treated and purified cellulase compositions and methods for reducing backstaining during enzymatic stonewashing
US7883872B2 (en)	1996-10-10	2011-02-08	Dyadic International (Usa), Inc.	Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
US6265204B1 (en)	1997-01-17	2001-07-24	Genencor International, Inc.	DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
ES2237159T3 (es)	1998-10-06	2005-07-16	Mark Aaron Emalfarb	Sistema de transformacion en el campo de los hongos micoticos filamentosos en chrysosporium.
US7189538B2 (en) *	1999-03-24	2007-03-13	Genencor International, Inc.	Hyphal growth in fungi
WO2001020007A1 (en) *	1999-09-13	2001-03-22	Concordia University	A multifunctional system for the efficient manipulation of protein expression in filamentous fungi and method using same
WO2002053758A2 (de) *	2000-12-29	2002-07-11	Rhein Biotech Gesellschaft für neue Biotechnologische Prozesse und Produkte mbH	Verfahren zum herstellen von heterologen proteinen in einem homothallischen pilz der familie sordariaceae
MXPA03008590A (es)	2001-03-22	2003-12-08	Novo Nordisk Healthcare Ag	Derivados del factor vii de coagulacion.
BR0212818A (pt)	2001-09-27	2004-10-05	Novo Nordisk Healthcare Ag	Polipeptìdeo de fator vii, construção de polionucletìdeo, célula hospedeira, animal transgênico, planta transgênica, método para produzir o polipeptìdeo de fator vii composição farmacêutica, uso de um polipeptìdeo de fator vii, e, método para o tratamento de distúrbios do sangramento em um sujeito ou para o aprimoramento do sistema hemostático normal
DK1495055T3 (da)	2002-04-18	2013-11-11	Genencor Int	Produktion af funktionelle antistoffer i filamentøse svampe
CA2498213C (en)	2002-09-10	2013-07-16	Genencor International, Inc.	Induction of gene expression using a high concentration sugar mixture
WO2004072225A2 (en)	2003-02-12	2004-08-26	Ramot At Tel Aviv University Ltd.	Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi
ES2381110T3 (es)	2003-09-09	2012-05-23	Novo Nordisk Health Care Ag	Polipéptidos de factor VII de coagulación
KR101348530B1 (ko)	2003-11-06	2014-02-14	다니스코 유에스 인크.	프로테아제 저해자 및 그 변이체의 사상균 내에서의 발현
CN102174490B (zh) *	2003-11-21	2016-09-28	丹尼斯科美国公司	颗粒淀粉水解酶在木霉菌中的表达和从颗粒淀粉底物产生葡萄糖的方法
CN1981037B (zh)	2004-05-27	2011-08-31	金克克国际有限公司	白曲霉酸稳定性α淀粉酶的异源表达和在颗粒淀粉水解中的应用
AU2005249422B2 (en)	2004-05-27	2011-03-17	Genencor International, Inc.	Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions
US7332319B2 (en)	2004-05-27	2008-02-19	Genencor International, Inc.	Heterologous alpha amylase expression in Aspergillus
US7413887B2 (en)	2004-05-27	2008-08-19	Genecor International, Inc.	Trichoderma reesei glucoamylase and homologs thereof
ATE530643T1 (de)	2004-12-30	2011-11-15	Genencor Int	Säureaktive fungale protease
ZA200706858B (en)	2005-02-18	2008-10-29	Genencor Int	Polypeptides having alpha-amylase and granular starch hydrolyzing activity
EP2314668B1 (de)	2005-04-12	2016-11-09	Danisco US Inc.	Gen-inaktivierte Mutanten mit geänderter Proteinproduktion
JP5690047B2 (ja)	2005-09-14	2015-03-25	ノボノルディスクヘルスケアアーゲー	ヒト凝固第ｖｉｉ因子ポリペプチド
US8198046B2 (en)	2006-07-11	2012-06-12	Danisco Us Inc.	KEX2 cleavage regions of recombinant fusion proteins
US20080026376A1 (en)	2006-07-11	2008-01-31	Huaming Wang	KEX2 cleavage regions of recombinant fusion proteins
US7968691B2 (en)	2006-08-23	2011-06-28	Danisco Us Inc.	Pullulanase variants with increased productivity
US8216844B2 (en)	2006-08-29	2012-07-10	Danisco Us Inc.	Compositions and methods for improved protein production
CN101522893B (zh)	2006-10-10	2014-07-09	丹尼斯科美国公司	具有改变性质的葡糖淀粉酶变体
EP2505651A3 (de)	2006-12-10	2013-01-09	Dyadic International, Inc.	Pilzisolate mit reduzierter Proteaseaktivität
US20080220498A1 (en)	2007-03-06	2008-09-11	Cervin Marguerite A	Variant Buttiauxella sp. phytases having altered properties
US8143046B2 (en)	2007-02-07	2012-03-27	Danisco Us Inc., Genencor Division	Variant Buttiauxella sp. phytases having altered properties
JP5167286B2 (ja)	2007-03-14	2013-03-21	ダニスコ・ユーエス・インク、ジェネンコー・ディビジョン	トリコデルマ・レセイ（ＴＲＩＣＨＯＤＥＲＭＡＲＥＥＳＥＩ）α−アミラーゼはマルトース産生酵素である。
DK2152892T3 (da)	2007-05-21	2013-07-22	Danisco Us Inc Genencor Div	Fremgangsmåde til indføring af nukleinsyrer i fungale celler
DK2147104T3 (en)	2007-05-21	2015-12-14	Danisco Us Inc	USING A ASPARAGINPROTEASE- (NSP24) SIGNAL SEQUENCE FOR heterologous protein EXPRESSION
CA2736661A1 (en)	2007-09-07	2009-03-12	Dyadic International, Inc.	Novel fungal enzymes
WO2009035500A1 (en)	2007-09-12	2009-03-19	Danisco Us Inc., Genencor Division	Trichoderma promoter
CA3069361C (en)	2007-10-09	2023-11-28	Danisco Us Inc.	Glucoamylase variants with altered properties
US8592194B2 (en)	2007-10-09	2013-11-26	Danisco Us Inc.	Glucoamylase variants with altered properties
EP3323889B1 (de)	2007-11-20	2020-03-25	Danisco US Inc.	Glucoamylasevarianten mit veränderten eigenschaften
CN105368764B (zh)	2007-12-13	2019-03-12	丹尼斯科美国公司	用于生产异戊二烯的组合物和方法
CN101918545A (zh)	2008-01-02	2010-12-15	丹尼斯科美国公司	应用嗜糖假单胞菌g4-淀粉酶和其变体获得乙醇的无葡糖淀粉酶的方法
CN101945996A (zh)	2008-02-11	2011-01-12	丹尼斯科美国公司	来自里氏木霉的具有微生物裂解活性的酶
EP2283124B1 (de)	2008-04-18	2016-05-25	Danisco US Inc.	Buttiauxella sp.-phytase-varianten
WO2009132220A2 (en)	2008-04-23	2009-10-29	Danisco Us Inc.	Isoprene synthase variants for improved microbial production of isoprene
MX318543B (es)	2008-07-02	2014-03-18	Danisco Us Inc	Composiciones y metodos para producir isopreno libre de hidrocarburos de c5 bajo condicion de desacoplamiento y/o intervalos de operacion seguros.
CA2737223A1 (en)	2008-09-15	2010-03-18	Danisco Us Inc.	Reduction of carbon dioxide emission during isoprene production by fermentation
EP2344629B1 (de)	2008-09-15	2018-01-24	Danisco US Inc.	Systeme mit verwendung von zellkultur zur isoprenherstellung
WO2010031062A1 (en)	2008-09-15	2010-03-18	Danisco Us Inc.	Increased isoprene production using the archaeal lower mevalonate pathway
EP2340312A2 (de)	2008-09-15	2011-07-06	Danisco US Inc.	Umwandlung von prenylderivaten in isopren
DK2358873T4 (en)	2008-12-15	2018-05-28	Danisco Us Inc	HYBRID ALPHA AMYLASER
MY161071A (en)	2008-12-30	2017-04-14	Danisco Us Inc	Methods of producing isoprene and a co-product
AU2010238770A1 (en)	2009-04-23	2011-11-03	Danisco Us Inc.	Three-dimensional structure of isoprene synthase and its use thereof for generating variants
EP3473711B1 (de)	2009-05-19	2020-11-04	DuPont Nutrition Biosciences ApS	Amylase polypeptide
TW201412988A (zh)	2009-06-17	2014-04-01	Danisco Us Inc	使用ｄｘｐ及ｍｖａ途徑之改良之異戊二烯製造
TWI434921B (zh)	2009-06-17	2014-04-21	Danisco Us Inc	從生物異戊二烯組合物製造燃料成分之方法及系統
US20120282285A1 (en)	2009-07-17	2012-11-08	Rigshospitalet	Masp isoforms as inhibitors of complement activation
AR077942A1 (es)	2009-08-19	2011-10-05	Danisco	Variantes de glucoamilasa
CN102712915B (zh)	2009-08-19	2014-12-10	丹尼斯科美国公司	具有改良比活和/或热稳定性的葡糖淀粉酶的组合变体
ES2583259T3 (es)	2009-12-01	2016-09-20	Novo Nordisk A/S	Nuevas liasas alfa-amidantes de peptidil alfa-hidroxiglicina
CA2791841C (en)	2010-03-05	2023-01-03	Rigshospitalet	Chimeric inhibitor molecules of complement activation
WO2011120993A1 (en)	2010-03-29	2011-10-06	Danisco A/S	Polypeptides having transgalactosylating activity
US8933282B2 (en)	2010-06-17	2015-01-13	Danisco Us Inc.	Fuel compositions comprising isoprene derivatives
DK2595488T3 (da) *	2010-07-21	2020-02-24	Novozymes As	Fremgangsmåde til fremstilling af et bagt produkt med antiældningsamylase og peptidase
CA2807558A1 (en)	2010-08-06	2012-02-09	Danisco Us Inc.	Production of isoprene under neutral ph conditions
BR112013001179A2 (pt)	2010-08-06	2016-05-31	Danisco Us Inc	sacrificação e fermentação em ph neutro.
EP2608682B1 (de)	2010-08-24	2017-12-13	Danisco US Inc.	Verfahren zur herstellung eines snackriegels mit einem niedrigtemperatur-reisproteinkonzentrat
CA2816306A1 (en)	2010-10-27	2012-05-03	Danisco Us Inc.	Isoprene synthase variants for improved production of isoprene
BR112013018316A2 (pt)	2010-12-22	2018-09-11	Danisco Us Inc	composições e métodos para produção aprimorada de isopreno usando dois tipos de enzimas ispg
JP2014502844A (ja)	2010-12-22	2014-02-06	ダニスコ・ユーエス・インク	組み換え細胞による五炭糖の生物学的生産
BR112013027170A2 (pt)	2011-04-29	2017-06-20	Danisco Us Inc	processo em ph único para liquefação e sacarificação de amido para xaropes de glicose de densidade alta
WO2013022799A1 (en)	2011-08-05	2013-02-14	Danisco Us Inc.	PRODUCTION OF ISOPRENOIDS UNDER NEUTRAL pH CONDITIONS
WO2013067028A1 (en)	2011-10-31	2013-05-10	Bp Corporation North America Inc.	Use of mammalian promoters in filamentous fungi
US9249418B2 (en)	2011-10-31	2016-02-02	Bp Corporation North America Inc.	Use of plant promoters in filamentous fungi
AU2013217986B2 (en)	2012-02-09	2017-04-27	Var2 Pharmaceuticals Aps	Targeting of chondroitin sulfate glycans
US9163263B2 (en)	2012-05-02	2015-10-20	The Goodyear Tire & Rubber Company	Identification of isoprene synthase variants with improved properties for the production of isoprene
WO2013182686A1 (en)	2012-06-08	2013-12-12	Dupont Nutrition Biosciences Aps	Polypeptides having transgalactosylating activity
MX2015002099A (es)	2012-08-22	2015-05-11	Dupont Nutrition Biosci Aps	Variantes que tienen actividad glucoamilasa.
CN104704118A (zh)	2012-10-15	2015-06-10	诺和诺德保健Ag（股份有限公司）	凝血因子vii多肽
WO2014145768A2 (en)	2013-03-15	2014-09-18	Bp Corporation North America Inc.	Use of non-fungal 5' utrs in filamentous fungi
EP4165999A1 (de)	2013-12-11	2023-04-19	DuPont Nutrition Biosciences ApS	Verfahren zur herstellung eines milchprodukts mit einem stabilen gehalt an galacto-oligosaccharid(en)
WO2016071504A1 (en)	2014-11-07	2016-05-12	Dupont Nutrition Biosciences Aps	Recombinant host cell expressing beta-galactosidase and/or transgalactosylating activity deficient in mannanase, cellulase and pectinase
BR112017016897A2 (pt)	2015-02-09	2018-03-27	Danisco Us Inc	cepas fúngicas e métodos de uso
ES2929531T3 (es)	2015-05-22	2022-11-30	Dupont Nutrition Biosci Aps	Acetolactato descarboxilasa
US20180148683A1 (en)	2015-07-07	2018-05-31	Danisco Us Inc.	Induction of gene expression using a high concentration sugar mixture
CA2997213C (en)	2015-09-02	2021-01-19	Dupont Nutrition Biosciences Aps	Glycoside hydolases and their use in preventing and/or treating a pathogenic infection in an animal
BR112018077458A2 (pt)	2016-06-30	2019-04-02	Danisco Us Inc.	proteases aspárticas
CA3037083A1 (en)	2016-09-16	2018-03-22	Dupont Nutrition Biosciences Aps	Acetolactate decarboxylase variants having improved specific activity
RU2763378C2 (ru)	2016-09-23	2021-12-28	ДюПон НЬЮТРИШН БАЙОСАЙЕНСИЗ АпС	ПРИМЕНЕНИЕ АКТИВНЫХ ПРИ НИЗКОМ ЗНАЧЕНИИ pH АЛЬФА-1,4/1,6-ГЛИКОЗИДГИДРОЛАЗ В КАЧЕСТВЕ КОРМОВОЙ ДОБАВКИ ДЛЯ ЖВАЧНЫХ ЖИВОТНЫХ ДЛЯ УЛУЧШЕНИЯ ПЕРЕВАРИВАНИЯ КРАХМАЛА
EP3523415A1 (de)	2016-10-04	2019-08-14	Danisco US Inc.	Herstellung von proteinen in fadenpilzzellen in abwesenheit von induzierenden substraten
WO2018093752A1 (en)	2016-11-15	2018-05-24	Danisco Us Inc.	Filamentous fungi with improved protein production
WO2018164876A1 (en)	2017-03-06	2018-09-13	Dupont Nutrition Biosciences Aps	Novel fungal fucosidases and their use in preventing and/or treating a pathogenic infection in an animal
US20210278406A1 (en)	2018-07-13	2021-09-09	Varct Diagnostic Aps	Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa
EP3935157A2 (de)	2019-03-08	2022-01-12	Danisco US Inc.	Fusionspolypeptide
CN113874392B (zh)	2019-03-28	2025-10-21	丹尼斯科美国公司	工程化抗体
JP7793519B2 (ja)	2019-12-19	2026-01-05	ビーエーエスエフソシエタス・ヨーロピア	ファインケミカルを生成する際の空時収率、炭素変換効率、及び炭素基質適応性の増加
KR20220119408A (ko)	2019-12-20	2022-08-29	바스프 에스이	터펜의 독성 감소 및 미생물에서 생산 잠재성 증가
WO2021202473A2 (en)	2020-03-30	2021-10-07	Danisco Us Inc	Engineered antibodies
EP4139332A1 (de)	2020-04-22	2023-03-01	Danisco US Inc.	Zusammensetzungen und verfahren zur verbesserten proteinproduktion in filamentösen pilzzellen
CN117716039A (zh)	2021-07-19	2024-03-15	丹尼斯科美国公司	用于增强真菌细胞中的蛋白质产生的组合物和方法
CN116135979B (zh) *	2021-11-16	2025-08-29	中国科学院天津工业生物技术研究所	一种基于流式细胞术的免涂板操作的菌株工程改造的方法及应用
JP2024542623A (ja)	2021-12-01	2024-11-15	ダニスコ・ユーエス・インク	真菌細胞におけるタンパク質生産を増強するための組成物及び方法
WO2024015953A1 (en)	2022-07-15	2024-01-18	Danisco Us Inc.	Methods for producing monoclonal antibodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4775622A (en) *	1982-03-08	1988-10-04	Genentech, Inc.	Expression, processing and secretion of heterologous protein by yeast
NO840200L (no) *	1983-01-28	1984-07-30	Cefus Corp	Glukoamylase cdna.
DK601984D0 (da) *	1984-12-14	1984-12-14	Hansens Lab	Fremgangsmaade til fremstilling af genprodukter
DE3650783T2 (de) *	1985-04-15	2004-07-15	Dsm Ip Assets B.V.	Verwendung des Glucoamylasepromotors aus Apergillus
DK122686D0 (da) *	1986-03-17	1986-03-17	Novo Industri As	Fremstilling af proteiner
FI872102A7 (fi) *	1986-06-06	1987-12-07	Panlabs Inc	Rihmasienten ilmentymisjärjestelmät.

1986
- 1986-08-27 DE DE3650202T patent/DE3650202T3/de not_active Expired - Lifetime
- 1986-08-27 EP EP94201751A patent/EP0625577A1/de not_active Withdrawn
- 1986-08-27 AU AU62008/86A patent/AU607398B2/en not_active Expired
- 1986-08-27 AT AT86306624T patent/ATE117020T1/de not_active IP Right Cessation
- 1986-08-27 EP EP86306624A patent/EP0215594B2/de not_active Expired - Lifetime
- 1986-08-27 NZ NZ217373A patent/NZ217373A/xx unknown
- 1986-08-28 CA CA000516993A patent/CA1341532C/en not_active Expired - Fee Related
- 1986-08-28 IE IE231086A patent/IE65794B1/en not_active IP Right Cessation
- 1986-08-28 IE IE950656A patent/IE950656L/xx unknown
- 1986-08-29 DK DK414486A patent/DK175460B1/da not_active IP Right Cessation
1996
- 1996-02-27 JP JP8040000A patent/JPH08280388A/ja active Pending
1998
- 1998-03-31 HK HK98102696A patent/HK1003579A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK414486D0 (da)	1986-08-29
EP0215594A2 (de)	1987-03-25
HK1003579A1 (en)	1998-10-30
DE3650202D1 (de)	1995-02-23
EP0215594A3 (en)	1988-08-31
AU6200886A (en)	1987-03-05
DE3650202T3 (de)	2004-06-03
IE950656L (en)	1987-02-28
NZ217373A (en)	1990-10-26
EP0215594B1 (de)	1995-01-11
DK414486A (da)	1987-03-01
IE862310L (en)	1987-02-28
CA1341532C (en)	2007-06-19
ATE117020T1 (de)	1995-01-15
EP0215594B2 (de)	2003-10-15
IE65794B1 (en)	1995-11-15
JPH08280388A (ja)	1996-10-29
AU607398B2 (en)	1991-03-07
DE3650202T2 (de)	1995-06-01
EP0625577A1 (de)	1994-11-23

Legal Events

Date	Code	Title	Description
2006-09-18	PUP	Patent expired

Publication	Publication Date	Title
DK175460B1 (da)	2004-11-01	Fremgangsmåde til fremstilling af et pattedyrpolypeptid
US5364770A (en)	1994-11-15	Heterologous polypeptides expressed in aspergillus
US6509171B1 (en)	2003-01-21	Aspartic proteinase deficient filamentous fungi
HK1003579B (en)	1998-10-30	Heterologous polypeptide expressed in filamentous fungi, processes for their preparation, and vectors for their preparation
Jeenes et al.	1991	9 Heterologous Protein Production by Filamentous Fungi
US5863759A (en)	1999-01-26	Process for the production of protein products in aspergillus
JP3005618B2 (ja)	2000-01-31	アスペルギルス属酵母のプロモーター
US5766912A (en)	1998-06-16	Humicola lipase produced in aspergillus
US5874558A (en)	1999-02-23	Nucleic acid encoding a recombinant humicola sp. lipase
JPH10500024A (ja)	1998-01-06	無毒、非毒素原性、非病原性の発現系、並びにその中で利用するためのプロモーター及びターミネーター
HUT51336A (en)	1990-04-28	Process for construction of aspergillus strains by gene substitution
JP3153234B2 (ja)	2001-04-03	糸状菌からの目的とするポリペプチドの分泌を増幅するｄｎａ配列、ベクター、及び融合ポリペプチド
DK175534B1 (da)	2004-11-22	Rekombinant DNA-molekyle, fremgangsmåde til dets fremstilling, transformeret vært, fremgangsmåde til dens fremstilling, fremgangsmåde til fremstilling af et polypeptid samt pectinlyaser
US6004785A (en)	1999-12-21	Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
Ward	1991	Chymosin production in Aspergillus
AU6323800A (en)	2001-02-19	Novel means of transformation of fungi and their use for heterologous protein production
US7776581B2 (en)	2010-08-17	Method of producing an aspartic protease in a recombinant host organism
Chiu	1988	Construction of a gene expression model in Mucor
JPH0538289A (ja)	1993-02-19	蛋白質の製造法